CANbridge Pharmaceuticals lands $98 mn Series D

China-based CANbridge Pharmaceuticals Inc., a biopharmaceutical company, has raised $98 million in Series D financing.

China-based CANbridge Pharmaceuticals Inc., a biopharmaceutical company, has raised $98 million in Series D financing. General Atlantic and WuXi AppTec led the round.

Source: Press Release